OM:BONEXBiotechs
Why Bonesupport Holding (OM:BONEX) Is Down 7.9% After Strong Double-Digit 2026 Sales Guidance - And What's Next
In January 2026, Bonesupport Holding AB issued earnings guidance indicating that fourth-quarter 2025 net sales are expected to reach SEK 313 million, representing 36.0% growth at constant exchange rates versus the prior-year period, and projected full-year 2026 sales growth above 35% at constant exchange rates.
This guidance highlights management’s confidence in sustaining rapid revenue expansion, suggesting that underlying demand for Bonesupport’s products may be broad-based across its core...